Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Melania Rocco
Sorafenib as Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Profile of Quizartinib for the Treatment of Adult Patients With Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date
Cancer Management and Research
Oncology
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia
Scientific Reports
Multidisciplinary
Synergistic Cell Death in FLT3-ITD Positive Acute Myeloid Leukemia by Combined Treatment With Metformin and 6-Benzylthioinosine
Leukemia Research
Cancer Research
Oncology
Hematology
Clofarabine, Cytarabine, and Mitoxantrone in Refractory/Relapsed Acute Myeloid Leukemia: High Response Rates and Effective Bridge to Allogeneic Hematopoietic Stem Cell Transplantation
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients With Relapsed/Refractory Acute Myeloid Leukemia
Advances in Hematology
Hematology
High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902
Leukemia Research
Cancer Research
Oncology
Hematology
